Learn more

SANKT PETERBURGSKIJ NII EPIDEM

Overview
  • Total Patents
    13
About

SANKT PETERBURGSKIJ NII EPIDEM has a total of 13 patent applications. Its first patent ever was published in 1991. It filed its patents most often in Russian Federation. Its main competitors in its focus markets environmental technology are CENTRUL NAT DE SANATATE PUBLICA AL MINISTERULUI SANATATII AL REPUBLICII MOLDOVA, YOSHIKANE MASAO and BAOMING LI.

Patent filings in countries

World map showing SANKT PETERBURGSKIJ NII EPIDEMs patent filings in countries
# Country Total Patents
#1 Russian Federation 13

Patent filings per year

Chart showing SANKT PETERBURGSKIJ NII EPIDEMs patent filings per year from 1900 to 2020

Focus industries

Focus technologies

Top inventors

# Name Total Patents
#1 Zhebrun Anatolij B 3
#2 Safonova Nina V 2
#3 Dovgal Svetlana G 2
#4 Kamalov Irik I 1
#5 Malkova Irina I 1
#6 Ilenko Vera I 1
#7 Gennadeva Tatyana Ya 1
#8 Meshalova Valentina N 1
#9 Boroznov Nikolaj I 1
#10 Taros Lyudmila Yu 1

Latest patents

Publication Filing date Title
RU2088662C1 Method of regeneration of virus measles vaccine strain
RU95108342A Strain of measles virus "orlov-b" for vaccine preparing
RU2091796C1 Method of chelicobacteriosis diagnosis
RU2082431C1 Method of preparing the inactivated antiinfluenza vaccine
RU2070929C1 Strain of virus "langat" for preparing living vaccine against tick-borne encephalitis
RU2052998C1 Method of immune complex state treatment
RU2067767C1 Method of preparing subunit gene engineering vaccine against hepatitis b
RU2039982C1 Method for estimating immunization effectiveness in the case of q fever
RU2026345C1 Strain of human rhotavirus for preparing of diagnostic and prophylaxis sera
RU2019189C1 Method for producing species-specific eimerian antigens
RU2017817C1 Nutrient medium for isolation of helicobacter pylori
RU2005779C1 Strain of bacterium leptospira interrogans of serogroup icterohaemorrhagiae, serovara copenhagent used for preparing of vaccine against leptospirosis
RU2017815C1 Strain of bacterium plesiomonas shigelloides 017 serovara used for hyperimmune serum preparing